Mainz Biomed N.V. - Ordinary Shares (NQ:MYNZ)

0.5759 -0.0141 (-2.39%)

Streaming Delayed Price Updated: 12:35 PM EST, Feb 24, 2026 Add to My Watchlist

Price and Volume

Volume	313,293
Open	0.5600
Bid (Size)	0.5800 (800)
Ask (Size)	0.6199 (2,000)
Prev. Close	0.5900
Today's Range	0.5476 - 0.6588
52wk Range	0.5511 - 6.290
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples

Today 7:30 EST

Mainz Biomed to Present Industry Leading Results: 100% Sensitivity and 95% Specificity

From Mainz BioMed NV

Via GlobeNewswire

Get insights into the top gainers and losers of Tuesday's after-hours session. ↗

February 17, 2026

Via Chartmill

Performance

YTD	-50.4%	-50.4%
1 Month	-55.7%	-55.7%
3 Month	-40.1%	-40.1%
6 Month	-66.5%	-66.5%
1 Year	-89.8%	-89.8%

More News

Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update

February 17, 2026

From Mainz BioMed NV

Via GlobeNewswire

Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting

January 14, 2026

From Mainz BioMed NV

Via GlobeNewswire

Mainz Biomed Provides Review of 2025 Highlights

January 05, 2026

From Mainz BioMed NV

Via GlobeNewswire

2 Small-Cap Biotechs That Could Reward Patient Investors ↗

December 12, 2025

Via MarketBeat

Get insights into the top gainers and losers of Wednesday's pre-market session. ↗

December 03, 2025

Via Chartmill

DoctorBox Adds Mainz Biomed’s ColoAlert(R) to Its Portfolio

December 02, 2025

From Mainz BioMed NV

Via GlobeNewswire

Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America

November 18, 2025

From Mainz BioMed NV

Via GlobeNewswire

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

November 13, 2025

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 13, 2025

Via Benzinga

Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025

November 12, 2025

From Mainz BioMed NV

Via GlobeNewswire

Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS)

November 10, 2025

From Mainz BioMed NV

Via GlobeNewswire

Mainz Biomed to Attend 2025 Maxim Growth Summit

October 15, 2025

From Mainz BioMed NV

Via GlobeNewswire

Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project

October 08, 2025

From Mainz BioMed NV

Via GlobeNewswire

Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting

September 30, 2025

From Mainz BioMed NV

Via GlobeNewswire

Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland

September 23, 2025

From Mainz BioMed NV

Via GlobeNewswire

Mainz Biomed Announces Registration of ColoAlert in the United Kingdom

September 02, 2025

From Mainz BioMed NV

Via GlobeNewswire

Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®

August 13, 2025

From Mainz BioMed NV

Via GlobeNewswire

Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants

August 04, 2025

From Mainz BioMed NV

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 01, 2025

Via Benzinga

Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies

July 23, 2025

From Mainz BioMed NV

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 16, 2025

Via Benzinga

Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition

July 15, 2025

From Mainz BioMed NV

Via GlobeNewswire

Frequently Asked Questions

Is Mainz Biomed N.V. - Ordinary Shares publicly traded?

Yes, Mainz Biomed N.V. - Ordinary Shares is publicly traded.

What exchange does Mainz Biomed N.V. - Ordinary Shares trade on?

Mainz Biomed N.V. - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Mainz Biomed N.V. - Ordinary Shares?

The ticker symbol for Mainz Biomed N.V. - Ordinary Shares is MYNZ on the Nasdaq Stock Market

What is the current price of Mainz Biomed N.V. - Ordinary Shares?

The current price of Mainz Biomed N.V. - Ordinary Shares is 0.5759

When was Mainz Biomed N.V. - Ordinary Shares last traded?

The last trade of Mainz Biomed N.V. - Ordinary Shares was at 02/24/26 12:35 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.